Nexgen Energy Ltd. Rises Amid Positive Nuclear Sector Sentiment
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 21 2026
0mins
Should l Buy NXE?
Source: Fool
Nexgen Energy Ltd. shares increased by 5.25% as it crossed above the 5-day SMA, reflecting strong investor interest in the nuclear energy sector.
The surge in Nexgen's stock is amid a broader rally in uranium and nuclear-related stocks following President Trump's remarks at the World Economic Forum, where he emphasized the importance of nuclear energy for U.S. manufacturing growth. This has led to increased market confidence in the nuclear sector, benefiting companies like Nexgen Energy.
The positive sentiment surrounding nuclear energy, coupled with rising electricity demand, positions Nexgen Energy favorably for future growth as the market shifts towards sustainable energy solutions.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy NXE?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on NXE
Wall Street analysts forecast NXE stock price to rise
4 Analyst Rating
4 Buy
0 Hold
0 Sell
Strong Buy
Current: 12.040
Low
10.78
Averages
12.84
High
14.37
Current: 12.040
Low
10.78
Averages
12.84
High
14.37
About NXE
NexGen Energy Ltd. is a Canadian company focused on delivering clean energy fuel for the future. It is engaged in the acquisition, exploration and evaluation and development of uranium properties in Canada. It is focused on optimally developing the Rook I Project. It has a portfolio of highly prospective projects, including its 100% owned Rook I property that is host to the high-grade Arrow Deposit, South Arrow, Harpoon, Bow, and the Cannon area. The Rook I Project is a development-stage uranium project in Canada. The new underground mine and mill development is located in the uranium-rich district of the southwestern area of the Athabasca Basin, located in Saskatchewan. Arrow is a 100% land-based, basement-hosted, and high-grade uranium discovery. The Rook I Project, host of the Arrow Deposit, which is a development-stage uranium project in Canada and is 100% owned by NexGen Energy Ltd. The Rook I property hosts the Harpoon Discovery located 4.7 km northeast of the Arrow Deposit.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Nuclear Expansion Initiative: President Trump's signing of four executive orders aims to quadruple U.S. nuclear capacity over the next 25 years, addressing the surging electricity demand driven by sectors like AI and quantum computing.
- Uranium Supply Shortage: With projections indicating a significant increase in uranium demand by 2026, domestic mine production is failing to meet reactor requirements, leading to a structural supply deficit that heightens investor focus on resource control.
- Merger Progress: The merger between Spring Valley Acquisition Corp. II and Eagle Energy Metals is advancing, with the SEC declaring its registration statement effective, and a shareholder vote scheduled for February 23, 2026, marking a critical step towards NASDAQ listing.
- Technological Investment: Eagle Energy Metals is collaborating with BBA USA Inc. to design a drilling campaign at the Aurora uranium project to support a Pre-Feasibility Study, which is expected to enhance its competitiveness in the U.S. uranium market to meet rising nuclear energy demands.
See More
- Nuclear Capacity Expansion: President Trump's signing of four executive orders aims to quadruple U.S. nuclear capacity over the next 25 years, addressing the increasing electricity demand driven by emerging technologies like AI and quantum computing that strain the grid.
- Merger Progress: The merger between Spring Valley Acquisition Corp. II and Eagle Energy Metals has received SEC registration approval, with a shareholder meeting scheduled for February 23, 2026, marking a significant step towards its NASDAQ listing.
- Uranium Supply Chain Investment: The U.S. Department of Energy's allocation of $2.7 billion to expand domestic uranium enrichment is expected to create thousands of jobs, further solidifying America's leadership in the global nuclear fuel supply chain.
- Mineral Resource Development: Eagle Energy Metals holds rights to a 32.75 million-pound uranium deposit on the Oregon-Nevada border and is collaborating with BBA USA Inc. on drilling activities to support its feasibility study, ensuring its asset can meet the growing uranium demand.
See More
- Approval Process: NexGen Energy's Rook I Project is undergoing the final step of the federal approval process at the CNSC hearing from February 9 to 12, 2026, concluding over 12 years of environmental and social studies that highlight the company's commitment to transparency and responsibility in resource development.
- Indigenous Support: Four identified Indigenous Nations are voicing their support for the NexGen project during the hearings, emphasizing the industry-leading approach the company has taken in engaging with local communities, which further solidifies the project's social license.
- Community Engagement: NexGen is showcasing a video during the hearing that highlights its community programs focused on education, training, and health, demonstrating the company's commitment to delivering lasting social and economic benefits through trust and partnership with local communities.
- Global Investment Opportunities: Listed on multiple stock exchanges, NexGen attracts global investors to participate in its mission addressing decarbonization and energy security, with the Rook I Project poised to become the largest low-cost uranium mine globally, driving sustainable development.
See More
- Impact of Short Report: NexGen Energy's shares fell by 8% following a short report from Culper Research, indicating market concerns about the company's future performance, which could undermine investor confidence and exacerbate stock price volatility.
- Disclosure of Short Shares: Culper Research disclosed its short position in NexGen Energy, suggesting skepticism about the company's profitability and growth prospects, potentially prompting more investors to reassess their holdings.
- Lack of Company Response: NexGen Energy did not promptly respond to Seeking Alpha's request for comment, which may raise questions about the company's transparency and communication capabilities, further impacting stock performance.
- Market Reaction Analysis: This stock price decline may lead investors to scrutinize NexGen Energy's fundamentals and future strategies, particularly whether its expansion plans in uranium mining can offset the prevailing negative market sentiment.
See More
- Significant Stock Decline: NexGen Energy Ltd. shares fell 10% on Friday, primarily due to Culper Research announcing a short position, indicating market concerns about the company's future prospects.
- Valuation Controversy: Culper Research alleged that the net present value of NexGen's Rook I project is overstated by 43% to 62%, which not only undermines investor confidence but could also complicate the company's financing efforts.
- Production Target Doubts: The report further claimed that NexGen's targeted peak annual uranium production of 29.7 million pounds is 'impossible to achieve,' exacerbating market skepticism regarding its operational capabilities and potentially impacting future production plans.
- Insider Enrichment Allegations: Culper described NexGen as 'an insider enrichment scheme,' which may attract regulatory scrutiny and increase the legal and compliance risks the company faces.
See More
- Complete Liquidation: Rye Brook Capital LLC disclosed in a recent SEC filing that it has fully exited its position in the iShares Biotechnology ETF by selling 24,270 shares for an estimated $3.50 million, indicating a significant shift in its investment strategy towards the biotech sector.
- Position Change: Following this transaction, Rye Brook Capital holds no shares in IBB, which previously represented 1.8% of its assets under management, highlighting a reassessment of the sector's outlook.
- Market Performance: As of January 26, 2026, IBB's share price stood at $175.85, reflecting a 27.4% increase over the past year, while the fund's one-year total return was 28.42%, showcasing the strong performance of the biotech industry.
- Investor Signal: The complete exit by Rye Brook Capital typically suggests concerns over industry valuations, potentially reflecting skepticism about future growth, especially after a period of strong merger and acquisition activity, leading investors to take profits.
See More











